Galmed Pharmaceuticals annual net debt
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Galmed Pharmaceuticals Net Debt Growth & History (GLMD)
Galmed Pharmaceuticals's net debt was −$4.0M for fiscal 2025.
View full Galmed Pharmaceuticals company overviewGalmed Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$4.0M | $667,000 | — |
| 2024 | 2024-12-31 | −$4.7M | −$1.8M | — |
| 2023 | 2023-12-31 | −$2.8M | −$1.0M | — |
| 2022 | 2022-12-31 | −$1.8M | $649,000 | — |
| 2021 | 2021-12-31 | −$2.4M | $4.1M | — |
| 2020 | 2020-12-31 | −$6.5M | $8.9M | — |
| 2019 | 2019-12-31 | −$15.4M | $8.8M | — |
| 2018 | 2018-12-31 | −$24.2M | −$11.1M | — |
| 2017 | 2017-12-31 | −$13.0M | −$10.7M | — |
| 2016 | 2016-12-31 | −$2.3M | $1.7M | — |
| 2015 | 2015-12-31 | −$4.0M | $19.4M | — |
| 2014 | 2014-12-31 | −$23.3M | −$23.6M | — |
| 2013 | 2013-12-31 | $291,000 | — | — |
Galmed Pharmaceuticals quarterly net debt
Q4.14
Q4.15
Q2.16
Q4.16
Q2.17
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.8M | $2.2M | — |
| Q4 2025 | 2025-12-31 | −$4.0M | $667,000 | — |
| Q3 2025 | 2025-09-30 | −$3.3M | — | — |
| Q2 2025 | 2025-06-30 | −$5.0M | — | — |
| Q4 2024 | 2024-12-31 | −$4.7M | −$1.8M | — |
| Q4 2023 | 2023-12-31 | −$2.8M | −$1.0M | — |
| Q4 2022 | 2022-12-31 | −$1.8M | $649,000 | — |
| Q2 2022 | 2022-06-30 | −$1.8M | $5.8M | — |
| Q4 2021 | 2021-12-31 | −$2.4M | $4.1M | — |
| Q2 2021 | 2021-06-30 | −$7.6M | −$2.3M | — |
| Q4 2020 | 2020-12-31 | −$6.5M | $8.9M | — |
| Q2 2020 | 2020-06-30 | −$5.3M | $20.0M | — |
| Q4 2019 | 2019-12-31 | −$15.4M | $8.8M | — |
| Q2 2019 | 2019-06-30 | −$25.3M | −$19.2M | — |
| Q4 2018 | 2018-12-31 | −$24.2M | −$11.1M | — |
| Q2 2018 | 2018-06-30 | −$6.2M | −$4.6M | — |
| Q4 2017 | 2017-12-31 | −$13.0M | −$10.7M | — |
| Q2 2017 | 2017-06-30 | −$1.6M | $1.1M | — |
| Q4 2016 | 2016-12-31 | −$2.3M | $1.7M | — |
| Q2 2016 | 2016-06-30 | −$2.7M | — | — |
| Q4 2015 | 2015-12-31 | −$4.0M | $19.4M | — |
| Q4 2014 | 2014-12-31 | −$23.3M | — | — |
Galmed Pharmaceuticals net debt trends
Over the last five fiscal years, Galmed Pharmaceuticals's net debt increased from −$6.5M to −$4.0M, a change of $2.5M. The latest reported quarter, Q2 2026, shows −$2.8M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Galmed Pharmaceuticals source filings ↗